FDA Adverse Event Malfunction Summary report: N

CUSTOM DISTAL FEMUR REPLACEMENT IMPLANT

MDR report key: 4361023 · Received December 19, 2014

Report

Report Number
3004105610-2014-00069
Event Type
Malfunction
Date Received
December 19, 2014
Date of Event
February 27, 2012
Report Date
February 16, 2012
Manufacturer
STANMORE IMPLANTS WORLDWIDE LTD
Product Code
KRO
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE DEVICE HISTORY WAS PERFORMED AND NO NON-CONFORMANCES WERE IDENTIFIED. CURRENT INFORMATION IS INSUFFICIENT TO PERMIT A CONCLUSION AS TO THE CAUSE OF THE REPORTED EVENT. REQUESTS ARE BEING MADE FOR ADDITIONAL INFORMATION AND A SUPPLEMENTAL REPORT WILL BE PROVIDED IF THIS INFORMATION IS RECEIVED. PLEASE NOTE THAT THIS CUSTOM IMPLANT IS SIMILAR TO THE METS MODULAR DISTAL FEMUR (K121029).

Additional Manufacturer Narrative · 1

A REBUSHING PROCEDURE WAS SUCCESSFULLY PERFORMED WITH NO REPORTED COMPLICATIONS. REBUSHING IS AN ANTICIPATED EVENT DUE TO THE NATURE AND DESIGN OF THE IMPLANT. IT CONSISTS OF THE REPLACEMENT OF POLY COMPONENTS WHICH ARE SUSCEPTIBLE TO WEAR SUCH AS BEARINGS AND BUSHINGS, IN ADDITION TO THE AXLE AND RELATED RETAINING MECHANISMS. THIS COMPLAINT IS BEING CLOSED AND IS BEING TRACKED AND TRENDED.

Description of Event or Problem · 1

IT WAS REPORTED BY THE SURGEON THAT THE PATIENT UNDERWENT A REBUSHING PROCEDURE ON (B)(6) 2006 AND SUBSEQUENTLY UNDERWENT A SECOND REBUSHING PROCEDURE ON (B)(6) 2012.

Description of Event or Problem · 1

THIS IS A SUPPLEMENTAL REPORT TO 3004105610-2014-00069 ((B)(4)). IT WAS REPORTED BY THE SURGEON THAT THE PATIENT UNDERWENT A REBUSHING PROCEDURE ON (B)(6) 2006 AND SUBSEQUENTLY UNDERWENT A SECOND REBUSHING PROCEDURE ON (B)(6) 2012.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
837989 CUSTOM DISTAL FEMUR REPLACEMENT IMPLANT DISTAL FEMUR IMPLANT KRO STANMORE IMPLANTS WORLDWIDE LTD BME12671

Patients

Seq Age Sex Outcome Treatment
1 56 YR Required Intervention